Implementation of Novel Quality Assurance Program for Hepatitis C Viral Load Point of Care Testing.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI

Hepatitis C*/diagnosis ; Point-of-Care Systems*; Humans ; Point-of-Care Testing ; Quality Control ; Viral Load

All patients should have access to accurate and timely test results. The introduction of point of care testing (PoCT) for infectious diseases has facilitated access to those unable to access traditional laboratory-based medical testing, including those living in remote and regional locations, or individuals who are marginalized or incarcerated individuals. In many countries, laboratory testing for infectious diseases, such as hepatitis C virus (HCV), is performed in a highly regulated environment. However, this is not the case for PoCT, where testing is performed by non-laboratory staff and quality controls are often lacking. An assessment of the provision of laboratory-based quality assurance to PoCT for infectious disease was conducted and the barriers to participation identified. A novel approach to providing quality assurance to PoCT sites, in particular those testing for HCV, was designed and piloted. This novel approach incudes identifying and validating sample types that are inactivated and stable at ambient temperature, creating cost-effective supply chains to facilitate logistics of samples, and the development of a smart phone-enabled portal for data entry and analyses. The creation and validation of this approach to quality assurance of PoCT removes the barriers to participation and acts to improve the quality and accuracy of testing, reduce errors and waste, and improve patient outcomes.

J Viral Hepat. 2019 Jul;26(7):919-922. (PMID: 30801881)
PLoS One. 2013;8(3):e59906. (PMID: 23527284)
BMC Res Notes. 2012 Mar 19;5:154. (PMID: 22429706)
PLoS One. 2015 Apr 17;10(4):e0123005. (PMID: 25885664)
J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21755. (PMID: 28872271)
J Virol Methods. 2010 Feb;163(2):295-300. (PMID: 19878697)
J Clin Virol. 2013 Dec;58 Suppl 1:e65-9. (PMID: 24342479)
JMIR Res Protoc. 2020 Jul 14;9(7):e16863. (PMID: 32673260)
BMJ Glob Health. 2020 Dec;5(12):. (PMID: 33328200)
J Virol Methods. 2020 Nov;285:113957. (PMID: 32805272)
J Virol Methods. 2013 Mar;188(1-2):1-5. (PMID: 23219930)
J Clin Microbiol. 2014 Mar;52(3):773-80. (PMID: 24353004)
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):e1-4. (PMID: 24933096)

Keywords: hepatitis C virus; pilot; point of care testing; quality assurance

Date Created: 20220923 Date Completed: 20220926 Latest Revision: 20221005

20250114

PMC9504144

10.3390/v14091929

36146736